中性粒细胞升高合并颅内动脉狭窄增加卒中复发风险
本研究基于CHANCE试验数据,纳入1034例小卒中或短暂性脑缺血发作患者,按中性粒细胞计数和颅内动脉狭窄状态分为4组。与中性粒细胞较低且无颅内动脉狭窄者相比,中性粒细胞较高且伴颅内动脉狭窄者卒中复发风险显著增加(校正HR 2.26,95%CI 1.19-4.31,P=0.01),复合血管事件风险亦增加(校正HR 1.98,95%CI 1.06-3.67,P=0.03),无安全性问题。
要点
- 中性粒细胞升高合并颅内动脉狭窄者卒中复发风险增加(校正HR 2.26)。
- 该组复合血管事件风险亦增加(校正HR 1.98)。
- 未观察到安全性问题。
核心结论
- 中性粒细胞水平较高且合并颅内动脉狭窄与已发生小缺血性卒中或高危短暂性脑缺血发作患者的卒中复发及复合不良结局事件风险增加相关。
研究设计与样本
- 基于CHANCE试验(氯吡格雷用于急性非致残性脑血管事件高危患者)数据的回顾性分析,纳入1034例患者,按中性粒细胞计数和颅内动脉狭窄状态二分类分为4组,采用Cox回归模型分析。
主要发现
- 1034例患者中91例发生卒中复发。
- 与中性粒细胞较低且无颅内动脉狭窄者相比,中性粒细胞较高且伴颅内动脉狭窄者卒中复发风险显著增加(校正HR 2.26,95%CI 1.19-4.31,P=0.01)。
- 与中性粒细胞较低且无颅内动脉狭窄者相比,中性粒细胞较高且伴颅内动脉狭窄者复合结局风险显著增加(校正HR 1.98,95%CI 1.06-3.67,P=0.03)。
- 未观察到安全性问题。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- The association of neutrophil and intracranial artery stenosis (ICAS) with the prognosis of stroke is uncertain. This study evaluated the relationship between neutrophil levels with and without ICAS and the prognosis of patients with minor stroke or transient ischemic attack. Methods- Data from the CHANCE trial (Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events) was reviewed. Patients were divided into 4 groups according to the dichotomy of neutrophil counts and status of ICAS. The primary outcome was a new stroke (ischemic or hemorrhagic), and secondary outcomes included a new composite vascular event (stroke, myocardial infarction, or cardiovascular death) and ischemic stroke. Safety outcome was any hemorrhage at 90 days. The association between neutrophil counts with and without ICAS and risk of any outcome was analyzed by Cox regression models. Results- Of 1034 patients included in this subgroup analysis, 91 had recurrent strokes. Compared with the lower neutrophil levels without ICAS, higher neutrophil levels with ICAS significantly increased the risk of stroke recurrence (adjusted hazard ratio, 2.26; 95% CI, 1.19-4.31; P=0.01) and composite outcome (adjusted hazard ratio, 1.98; 95% CI, 1.06-3.67; P=0.03). However, there was no safety issue. Conclusions- Concomitant presence of higher neutrophil levels and ICAS was associated with the increased risk of stroke recurrence, and combined adverse outcome events in patients already had minor ischemic stroke or high-risk transient ischemic attack. Clinical Trial Registration- URL: https://www.clinicaltrials.gov . Unique identifier: NCT00979589.
引用
- Zhu B, Liu H, Pan Y, et al. Elevated Neutrophil and Presence of Intracranial Artery Stenosis Increase the Risk of Recurrent Stroke. Stroke. 2018. PMID: 30355101. doi:10.1161/STROKEAHA.118.022126
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。